Literature DB >> 29920884

Safety and effectiveness of 'hospital in the home' and 'outpatient parenteral antimicrobial therapy' in different age groups: A systematic review of observational studies.

Shanthy Sriskandarajah1, Jodie Hobbs1, Elizabeth Roughead2, Melissa Ryan1, Karen Reynolds1.   

Abstract

OBJECTIVE: The aim of this study was .to systematically review the published literature of observational studies evaluating the safety and effectiveness of hospital in the home (HITH) and outpatient parenteral antimicrobial therapy (OPAT) in the general population, older people and children. STUDY
DESIGN: The review included retrospective studies and prospective studies performed on HITH and OPAT within different age groups. Only the studies that analysed the safety and effectiveness of HITH and OPAT were included for review. DATA SOURCES: A literature search of electronic databases CINAHL, Web of Science, PubMed and SCOPUS from 1997 to 2016 was performed. DATA SYNTHESIS: Forty-four studies met the inclusion criteria. Five studies were undertaken on HITH within the general population, 26 studies were undertaken on OPAT within the general population, 8 studies were on HITH and OPAT for older people and 5 studies were on OPAT with children. More than 88% of the studies reported a cure or treatment success rate of greater than 80%. Adverse events with drugs ranged from 0% to 30.2%; adverse events with vascular access devices ranged from 0% to 29%; readmission rate varied from 1% to 26%; mortality varied from 0% to 27.5%.
CONCLUSIONS: This review quantifies the rates of success and harm in real world practice, and demonstrates that while most patients experience treatment success, adverse events may be high in some groups. However, the methodologies used to measure these parameters were inconsistent and some demographic groups had only a small number of studies.
© 2018 John Wiley & Sons Ltd.

Entities:  

Year:  2018        PMID: 29920884     DOI: 10.1111/ijcp.13216

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  6 in total

1.  Comparing peripherally inserted central catheter-related practices across hospitals with different insertion models: a multisite qualitative study.

Authors:  Sarah L Krein; Molly Harrod; Lauren E Weston; Brittani R Garlick; Martha Quinn; Kathlyn E Fletcher; Vineet Chopra
Journal:  BMJ Qual Saf       Date:  2020-12-24       Impact factor: 7.418

2.  Being 'at-home' on outpatient parenteral antimicrobial therapy (OPAT): a qualitative study of parents' experiences of paediatric OPAT.

Authors:  Bernie Carter; Debra Fisher-Smith; David Porter; Steven Lane; Matthew Peak; David Taylor-Robinson; Louise Bracken; Enitan Carrol
Journal:  Arch Dis Child       Date:  2019-09-26       Impact factor: 3.791

3.  Comparison of Hospital-at-Home models: a systematic review of reviews.

Authors:  Man Qing Leong; Cher Wee Lim; Yi Feng Lai
Journal:  BMJ Open       Date:  2021-01-29       Impact factor: 2.692

Review 4.  Clinic- and Hospital-Based Home Care, Outpatient Parenteral Antimicrobial Therapy (OPAT) and the Evolving Clinical Responsibilities of the Pharmacist.

Authors:  Toni Docherty; Jennifer J Schneider; Joyce Cooper
Journal:  Pharmacy (Basel)       Date:  2020-12-07

5.  Paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): An e-survey of the experiences of parents and clinicians.

Authors:  Bernie Carter; Debra Fisher-Smith; David Porter; Steven Lane; Matthew Peak; David Taylor-Robinson; Louise Bracken; Enitan D Carrol
Journal:  PLoS One       Date:  2021-04-02       Impact factor: 3.240

6.  Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT.

Authors:  Laura Herrera-Hidalgo; Rafael Luque-Márquez; Aristides de Alarcon; Ana Belén Guisado-Gil; Belen Gutierrez-Gutierrez; Maria Dolores Navarro-Amuedo; Julia Praena-Segovia; Juan Manuel Carmona-Caballero; Elena Fraile-Ramos; Alicia Gutierrez-Valencia; Luis Eduardo Lopez-Cortes; Maria Victoria Gil-Navarro
Journal:  J Clin Med       Date:  2022-03-11       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.